Ahammune Biosciences Secures $5M for Vitiligo Trials
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
- Latest
- Trending
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Tula's DMD improves EV efficiency by 0.6% in China. Further gains expected, aiding the EV transition.
Explore AST SpaceMobile's satellite innovations and investment potential amidst the evolving space industry landscape.
Cyngn Inc. has expanded its IP portfolio with a new US patent focused on adaptive traffic rule-based decision-making for autonomous ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.